WASHINGTON (dpa-AFX) - THL Partners, Thursday announced an agreement to Headlands Research, a multinational network of clinical trial sites, from funds managed by KKR & Co. Inc. (KKR).
The deal is expected to boost Headlands' continued expansion, enhance its technology and centralized infrastructure, and further strengthen its ability to deliver high-quality, diverse clinical trial data for pharmaceutical and biotech sponsors.
THL will finance the deal, expected to close this year, with its flagship Fund IX.
Currently, KKR is trading at $146.40, down 0.81 percent on the New York Stock Exchange.
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News